Efficacy of recombinant Bacillus Calmette-Guérin containing dltA in <i>in vivo</i> three-dimensional bio-printed bladder cancer-on-a-chip and <i>ex vivo</i> orthotopic mouse model.

Investig Clin Urol · 2023 · PMC10172047 · PMID 37341010

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

On the tenth day, all groups showed an increasing trend in BLI intensity; BLI intensity (mean±standard error, ×10 9 ) were significantly lower in the rBCG-dltA 30 MOI group than in the control (32.5±1.9 vs 257.3±82.6, p<0.01) and mock BCG 30 MOI (32.5±1.9 vs. 152.3±10.7, p<0.05) groups ( Fig. 5 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.